<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00421564</url>
  </required_header>
  <id_info>
    <org_study_id>ICM/CTS/004</org_study_id>
    <nct_id>NCT00421564</nct_id>
  </id_info>
  <brief_title>Study the Effect of Danggui Buxue Tang on Menopausal Symptoms</brief_title>
  <official_title>A Randomized, Double-Blind, Placebo Controlled Study of the Effect of Danggui Buxue Tang on Menopausal Symptoms and Quality of Life in Hong Kong Chinese Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese University of Hong Kong</source>
  <brief_summary>
    <textblock>
      This study is to examine the effect and safety of the study drug,Danggui Buxue Tang, on
      menopausal symptoms of hot flushes and sweating and to determine whether the patient's
      quality of life will be improved.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2003</start_date>
  <completion_date>December 2004</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Changes in severity and frequency of hot flushes and sweats.</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Changes in score of the Menopause Specific Quality of Life and the values of various markers of risk for cardiovascular disease.</measure>
  </secondary_outcome>
  <enrollment>100</enrollment>
  <condition>Menopause</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>DBT-Danggui Buxue Tang</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Follicle stimulating hormone (FSH), luteinizing hormone (LH), oestradiol in the
             menopausal range (FSH&gt;18 IU/L, LH&gt;12.6 IU/L, and E2&lt; 361 pmol/l).

          -  Patients with amenorrhoea for more than 12 months

        Exclusion Criteria:

          -  Patients with a history of using any form of hormonal replacement therapy within 8
             weeks

          -  Patients with a history of using Chinese medicine or other therapies which may affect
             the outcome within 8 weeks

          -  Patients who in the judgment of the investigator will be unable to comply with
             protocol requirements

          -  Patients with significant** gastrointestinal, renal, hepatic, bronchopulmonary,
             neurological, cardiovascular, breast or endometrial carcinoma, or allergic diseases

          -  Patients with uncontrolled hypertension

          -  Patients with undiagnosed vaginal bleeding

          -  Patients with a history of significant drug hypersensitivity
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christopher J Haines, FPOGS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Obstetrics &amp; Gynaecology, CUHK</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Obstetrics &amp; Gynaecology, CUHK, Prince of Wales Hospital</name>
      <address>
        <city>Hong Kong</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Hagstad A, Janson PO. The epidemiology of climacteric symptoms. Acta Obstet Gynecol Scand Suppl. 1986;134:59-65.</citation>
    <PMID>3468732</PMID>
  </reference>
  <reference>
    <citation>Schneider HP, Gallagher JC. Moderation of the daily dose of HRT: benefits for patients. Maturitas. 1999 Nov;33 Suppl 1:S25-9.</citation>
    <PMID>10661612</PMID>
  </reference>
  <reference>
    <citation>Au GK. Evaluation of the benefits and risks of hormone replacement therapy. Hong Kong Med J. 2000 Dec;6(4):381-9. Review.</citation>
    <PMID>11177160</PMID>
  </reference>
  <reference>
    <citation>Blumel JE, Castelo-Branco C, Binfa L, Gramegna G, Tacla X, Aracena B, Cumsille MA, Sanjuan A. Quality of life after the menopause: a population study. Maturitas. 2000 Jan 15;34(1):17-23.</citation>
    <PMID>10687878</PMID>
  </reference>
  <reference>
    <citation>Hall G, Pripp U, Schenck-Gustafsson K, Landgren BM. Long-term effects of hormone replacement therapy on symptoms of angina pectoris, quality of life and compliance in women with coronary artery disease. Maturitas. 1998 Jan 12;28(3):235-42.</citation>
    <PMID>9571599</PMID>
  </reference>
  <reference>
    <citation>Zhu DP. Dong quai. Am J Chin Med. 1987;15(3-4):117-25.</citation>
    <PMID>3425569</PMID>
  </reference>
  <reference>
    <citation>Davis SR, Briganti EM, Chen RQ, Dalais FS, Bailey M, Burger HG. The effects of Chinese medicinal herbs on postmenopausal vasomotor symptoms of Australian women. A randomised controlled trial. Med J Aust. 2001 Jan 15;174(2):68-71.</citation>
    <PMID>11245505</PMID>
  </reference>
  <reference>
    <citation>Fugh-Berman A. Herb-drug interactions. Lancet. 2000 Jan 8;355(9198):134-8. Review. Erratum in: Lancet 2000 Mar 18;355(9208):1020.</citation>
    <PMID>10675182</PMID>
  </reference>
  <reference>
    <citation>Chung TK, Yip SK, Lam P, Chang AM, Haines CJ. A randomized, double-blind, placebo-controlled, crossover study on the effect of oral oestradiol on acute menopausal symptoms. Maturitas. 1996 Oct;25(2):115-23.</citation>
    <PMID>8905602</PMID>
  </reference>
  <verification_date>January 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 11, 2007</study_first_submitted>
  <study_first_submitted_qc>January 11, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 12, 2007</study_first_posted>
  <last_update_submitted>January 11, 2007</last_update_submitted>
  <last_update_submitted_qc>January 11, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 12, 2007</last_update_posted>
  <keyword>Menopausal</keyword>
  <keyword>Traditional Chinese Medicine</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

